EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic Impact of Pulmonary Metastasectomy for Uterine Malignancies: A Retrospective Analysis of 38 Cases

Hiroyuki Adachi iD, Hiroyuki Ito, Takuya Nagashima iD, Tetsuya Isaka, Kotaro Murakami iD, Noritake Kikunishi iD, Naoko Shigeta, Aya Saito

Cancers · 19.12.2025 · 18 (1) · 13

DOI: 10.3390/cancers18010013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 19.12.2025. Verfasst von Hiroyuki Adachi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi, Yokohama 241-8515, Japan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Uterine malignancies frequently metastasize to the lungs. Pulmonary metastasectomy has demonstrated survival benefits in some malignancies; however, its efficacy for uterine malignancies remains unclear.

Methods

We retrospectively analyzed 38 patients who underwent pulmonary metastasectomy for uterine malignancies at the Kanagawa Cancer Center between 2010 and 2020. The primary endpoint was recurrence-free survival (RFS) after pulmonary resection.

Results

The median patient age was 63 years. The primary sites were the cervical uteri (n = 22) and corpus uteri (n = 16). The FIGO stages at the time of treatment for the primary tumor were I, II, III, IV, and unknown in 20, 7, 9, 1, and 1 patient, respectively. The median disease-free interval (DFI), defined as the interval between primary treatment and first recurrence, was 26.5 months. Most patients had single metastasis (n = 32). The procedures for metastasectomy included lobectomy, segmentectomy, and wedge resection (n = 15, 8, and 15, respectively), and two cases resulted in microscopically incomplete resection. The median follow-up period after pulmonary metastasectomy was 57 months, with 16 patients experiencing recurrence after pulmonary metastasectomy (5-year RFS rate: 55.6%). Univariate analysis identified FIGO stage ≥ III, DFI < 12 months, presence of synchronous extrapulmonary recurrence, and uterine sarcoma as poor prognostic factors. No prognostic differences were found between cervical and corpus uteri cancers.

Conclusions

Pulmonary metastasectomy may confer prognostic benefits in patients with uterine malignancies. Careful consideration is warranted for patients with advanced-stage primary tumors, early recurrence after primary treatment, synchronous extrapulmonary recurrence, and uterine sarcoma.

Schlagwörter

Stichwörter der Autor:innen

cervical cancercervix utericorpus uteripulmonary metastasectomyuterine cancer

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi, Yokohama 241-8515, Japan.
  • Department of Surgery, Yokohama City University, Yokohama 236-0004, Japan.

ORCID-Profile: Hiroyuki Adachi, Takuya Nagashima, Kotaro Murakami, Noritake Kikunishi

Zitieren

APA

Adachi, H., Ito, H., Nagashima, T., Isaka, T., Murakami, K., Kikunishi, N., Shigeta, N., & Saito, A. (2025). Prognostic Impact of Pulmonary Metastasectomy for Uterine Malignancies: A Retrospective Analysis of 38 Cases. Cancers, 18(1), 13. https://doi.org/10.3390/cancers18010013

Vancouver

Adachi H, Ito H, Nagashima T, Isaka T, Murakami K, Kikunishi N, et al. Prognostic Impact of Pulmonary Metastasectomy for Uterine Malignancies: A Retrospective Analysis of 38 Cases. Cancers. 2025;18(1):13. doi:10.3390/cancers18010013

BibTeX
@article{Adachi2025,
  author = {Adachi, Hiroyuki and Ito, Hiroyuki and Nagashima, Takuya and Isaka, Tetsuya and Murakami, Kotaro and Kikunishi, Noritake and Shigeta, Naoko and Saito, Aya},
  title = {Prognostic Impact of Pulmonary Metastasectomy for Uterine Malignancies: A Retrospective Analysis of 38 Cases},
  journal = {Cancers},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {13},
  doi = {10.3390/cancers18010013}
}
Kostenlos starten →